Thank you to everyone who visited PurpleAI at Booth E-21 & E-22 at KCR 2026.
Over four days at the 82nd Korean Congress of Radiology (KINTEX, Goyang), we demonstrated the Hyper Insight stroke AI portfolio to radiologists and clinicians from Korea and abroad.
Our core CT stroke suite:
- Hyper Insight-ICH (FDA-cleared)
- Hyper Insight-ICH Plus (MFDS-approved)
- Hyper Insight-Infarct: (MFDS-approved)
- Hyper Insight-ASPECTS (MFDS-approved)
- Hyper Insight-CTA Aneurysm (MFDS-approved)
Our newest solutions:
- Hyper Insight-CTA 3D
- Hyper Insight-CTP
- Hyper Insight-DWI Infarct
On Friday, we also hosted overseas radiology society delegates and invited speakers on the KCR 2026 international VIP booth tour.
Thank you for the thoughtful questions and candid feedback. We look forward to continuing these conversations.
Stroke AI: Real-Time Detection. Predictive Intelligence.